Etoricoxib – 15 years in Russia: the main results in the treatment of rheumatic diseases
Background. According to epidemiological studies, chronic musculoskeletal pain affects more than 30% of people worldwide, causing a huge personal and social burden. Nonsteroidal anti-inflammatory drugs are widely used to treat musculoskeletal pain. The drug etoricoxib, highly selective for COX-2, is...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Open Systems Publication
2024-01-01
|
| Serija: | Лечащий Врач |
| Teme: | |
| Online pristup: | https://journal.lvrach.ru/jour/article/view/1179 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|